Cargando…
Live biotherapeutic products: the importance of a defined regulatory framework
Probiotics have been defined as “Live microorganisms that when administered in adequate amounts confer a health benefit on the host”. This definition covers a wide range of applications, target populations and (combinations of) microorganisms. Improved knowledge on the importance of the microbiota i...
Autores principales: | Cordaillat-Simmons, Magali, Rouanet, Alice, Pot, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080583/ https://www.ncbi.nlm.nih.gov/pubmed/32908212 http://dx.doi.org/10.1038/s12276-020-0437-6 |
Ejemplares similares
-
Entering First-in-Human Clinical Study With a Single-Strain Live Biotherapeutic Product: Input and Feedback Gained From the EMA and the FDA
por: Paquet, Jeanne-Céleste, et al.
Publicado: (2021) -
Factors that influence clinical efficacy of live biotherapeutic products
por: Pot, Bruno, et al.
Publicado: (2021) -
Live Biotherapeutic Products, A Road Map for Safety Assessment
por: Rouanet, Alice, et al.
Publicado: (2020) -
Editorial: Synthetic Live Biotherapeutic Products for Diseases
por: Chen, Ye, et al.
Publicado: (2022) -
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023)